Viatris (VTRS) Shares Outstanding (2019 - 2026)
Viatris (VTRS) posted quarterly Shares Outstanding (Entity) of $1.3 billion for Q1 2026, up 1.1% year-over-year from $1.2 billion in Q1 2025, and up 1.06% quarter-over-quarter from $1.2 billion in Q4 2025.
Viatris (VTRS) Shares Outstanding (2019 - 2026) Analysis & Trends
Viatris' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $1.3 billion for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.1% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 1.1% YoY), while the FY2025 annual figure was $1.2 billion, up 0.91% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $1.3 billion, up from $1.2 billion in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $1.3 billion in Q1 2026, with the low at $1.2 billion in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $1.2 billion (2024), against an average of $1.2 billion.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) rose 0.27% in 2022, then grew 1.14% in 2025.
- Viatris' Shares Outstanding (Entity) stood at $1.2 billion in 2022, then grew by 0.68% to $1.2 billion in 2023, then increased by 0.99% to $1.2 billion in 2024, then advanced by 0.91% to $1.2 billion in 2025, then rose by 1.06% to $1.3 billion in 2026.
- Business Quant data shows VTRS's Shares Outstanding (Entity) at $1.3 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 167.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.16 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.17 Bn |
| Mar 31, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.19 Bn |
| Sep 30, 2024 | 1.19 Bn |
| Jun 30, 2024 | 1.19 Bn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.21 Bn |
| Jun 30, 2022 | 1.21 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.21 Bn |